共 48 条
[1]
Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, (2013)
[2]
Holschneider C.H., Berek J.S., Ovarian cancer: epidemiology, biology, and prognostic factors, Semin Surg Oncol, 19, 1, pp. 3-10, (2000)
[3]
Pathology and genetics of tumours of the breast and female genital organs, IARC, (2003)
[4]
Son H., Khan S.M., Rahaman J., Cameron K.L., Prasad-Hayes M., Chuang L., Et al., Role of FDG PET/CT in staging of recurrent ovarian cancer, Radiographics, 31, 2, pp. 569-583, (2011)
[5]
Holcomb K., Vucetic Z., Miller M.C., Knapp R.C., Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women, Am J Obstet Gynecol, 205, 4, pp. 358.e1-6, (2011)
[6]
Bandiera E., Romani C., Specchia C., Zanotti L., Galli C., Ruggeri G., Et al., Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management, Cancer Epidemiol Biomarkers Prev, 20, 12, pp. 2496-2506, (2011)
[7]
Jeong Y.Y., Outwater E.K., Kang H.K., Imaging evaluation of ovarian masses, Radiographics, 20, 5, pp. 1445-1470, (2000)
[8]
Iyer V.R., Lee S.I., MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization, AJR Am J Roentgenol, 194, 2, pp. 311-321, (2010)
[9]
Wu Y., Peng H., Zhao X., Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis, Ultrasound Med Biol, 41, 4, pp. 967-974, (2015)
[10]
Levine D., Brown D.L., Andreotti R.F., Benacerraf B., Benson C.B., Brewster W.R., Et al., Society of Radiologists in Ultrasound. Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement, Ultrasound Q, 26, 3, pp. 121-131, (2010)